Jacobs Levy Equity Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,299
| Closed | -$426K | – | 1059 |
|
|
2025
Q1 | $426K | Sell |
21,299
-113,483
| -84% | -$2.27M | ﹤0.01% | 936 |
|
|
2024
Q4 | $3.59M | Sell |
134,782
-361,739
| -73% | -$9.64M | 0.01% | 485 |
|
|
2024
Q3 | $14.2M | Sell |
496,521
-21,456
| -4% | -$612K | 0.05% | 279 |
|
|
2024
Q2 | $11.3M | Sell |
517,977
-13,925
| -3% | -$303K | 0.05% | 316 |
|
|
2024
Q1 | $11.8M | Sell |
531,902
-4,885
| -0.9% | -$108K | 0.05% | 274 |
|
|
2023
Q4 | $11.6M | Sell |
536,787
-10,616
| -2% | -$229K | 0.06% | 287 |
|
|
2023
Q3 | $9.25M | Buy |
547,403
+289,252
| +112% | +$4.89M | 0.05% | 271 |
|
|
2023
Q2 | $3.54M | Buy |
+258,151
| New | +$3.54M | 0.02% | 470 |
|